comparemela.com

Latest Breaking News On - Francesco de rubertis - Page 4 : comparemela.com

Granular boosts mast cell disease programme

Therapy candidates chosen for lead projects targeting mast cell driven diseases - News - PharmaTimes

Jonny finlayBrian kimFrancesco de rubertisGranular therapeuticsMast cell

Granula Therapeutics: Granular Therapeutics to accelerate development of next-generation pipeline for treating mast cell driven diseases

Clinical candidate selection finalised for lead programme targeting mast-cell driven diseases Dermatology industry veteran Thibaud Portal, PhD appointed as CEO LONDON, March 30, 2023

City ofUnited kingdomJamie colemanOrla cunninghamFrancesco de rubertisJonny finlayBrian kimPfizer biomedicine design groupThibaud portalGranular therapeuticsScientific advisory boardChief executivePrescription medicinesChief executive officerUnited kingdom basedBiotech ultrahuman

Granular Therapeutics to accelerate development of next-generation pipeline for treating mast cell driven diseases

/PRNewswire/ Granular Therapeutics, (Granular) a private biotech company specialising in precision biologic therapies for treating mast cell driven.

City ofUnited kingdomOrla cunninghamBrian kimJonny finlayJamie colemanFrancesco de rubertisPfizer biomedicine design groupThibaud portalGranular therapeuticsScientific advisory boardChief executivePrescription medicinesChief executive officerUnited kingdom basedBiotech ultrahuman

Aldena Therapeutics Accelerates its Novel and Disruptive Approach to Immuno-Dermatology

/PRNewswire/ Aldena Therapeutics Inc. (Aldena) a private biotech company pioneering siRNA-based therapies for dermatological indications, announces an.

United statesCity ofUnited kingdomJonathan silverbergCraig melloFrancesco de rubertisAnastasia khvorovaMark prausnitzCraigc melloJohn harrisInternational societies for investigative dermatology meetingBlais universityAmerican dermatological associationDermatology innovation forumUniversity of massachusetts chan medical schoolInternational society for atopic dermatitis

Sollum Technologies nabs $30m: the week in agrifoodtech

Plus: Multus Biotechnology secures Series A funding, Danone announces plans to reduce methane and Nest's co-founder launches a circular economy trash bin.

United kingdomFrancesco de rubertisMatt rogerLive green coSollum technologiesIdealist capitalGreenhouse managementLiving carbonLowercarbon capitalEagle genomicsEagle genomicBusiness weeklyCleveland avenuePlanet capitalOceans venturesSerena ventures

vimarsana © 2020. All Rights Reserved.